An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.
The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.
References
Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).
Recent Posts
EHDI Program Eliminated
On April 1, President Trump’s administration eliminated the entire branch of the Early Hearing Detection and Intervention (EHDI) program that works with states to analyze…
Speak Up Today: Modernize Medicare Payment Policy
Congress is preparing to take action on a budget reconciliation package the week of May 5, and now is a critical time for the audiology…
Volunteers Sought for Scholarship Review Task Force
Ready to make a meaningful impact? Join us as a volunteer for the 2025 Scholarship Review Task Force and help shape the future of tomorrow’s…